Pharmacology Week 4-6 Flashcards
(100 cards)
1 in how many Australians reported having….
-osteoarthritis?
-osteoporosis or osteopenia?
- osteoarthritis 1 in 11 more so in F
- osteoporosis 1 in 5
People with back pain and problems were how many more times likely to experience…..
- poor health?
- very high psychological distress?
- very severe pain?
- PH: 3.2X
- PD: 1.8x
- SP: 2.4X
People with arthritis were how many more times likely to experience…..
- poor health?
- very high psychological distress?
- very severe pain?
- PH: 2.7x
- PD: 1.8X
- SP: 2.3X
People with osteoporosis were how many more times likely to experience…..
- poor health?
- very high psychological distress?
- very severe pain?
- PH: 2.0X
- PD: 1.9X
- 3.0X
Ankylosing spondylitis, psoriatic arthritis, reactive arthritis, enteropathic arthritis are all examples of what type of musculoskeletal disorder?
spondyloarthropathies
autoimmune disease that features painful swelling and stiffness in joints that is a systemic condition
rheumatoid arthritis (RA)
What happens at the cellular level in rheumatoid arthritis (RA)?
T cells invade the _____________ and produce _________ and _________
synovial membrane
interleukin-2
interferon
interleukin-2 and interferon signal a cascade reaction leading to an overproduction of ______________ which constitute the pivotal event leading to chronic inflammation
pro-inflammatory cytokines, mainly TNF-, IL-1 and IL-6
What are the stages of Rheumatoid arthritis?
1) synovitis
2) pannus formation
3) fibrous ankylosis
4) bony ankylosis
What is the general pharmaceutical management of Rheumatoid arthritis?
Disease Modifying Anti-Rheumatic Drugs (DMARDs)
What are the 3 main areas of pharmacological management of rheumatoid arthritis?
- pain management w/ analgesics
- disease modification with DMARDS w/ corticosteroids
- aggressive management of co-morbidities such as cardiovascular risk factors
reduce or eradicate synovial inflammation and thus prevent joint damage
disease modifying anti-rheumatic drugs (DMARDs)
When should a response with DMARDs therapy be expected?
apparent within 12 weeks
What is the most common DMARDs choice?
Methotrexate (MTX) in active cases which also is a common cancer drug
(combination therapy results in superior outcomes)
Methotrexate….
-what is it
- onset of action:
- often prescribes with:
- anti inflammatory, immunomodulatory and cytotoxic action
- w/in 3-6 weeks
- folic acid to reduce adverse effects
What are common adverse effects with methotrexate?
- nausea
- increase in rheumatoid arthritis
- mouth ulcers
- rash
- reversible hair loss
conventional synthetic DMARD that is an antimalarial that possesses anti-inflammatory and possibly immunosuppressive activity
hydroxychloroquine
What is the benefit to taking hydroxychloroquine too MTX?
better tolerated but less effective
What is the response onset of hydroxychloroquine?
2-6 months
Common adverse effects with hydroxychloroquine:
- nausea/ anorexia/ diarrhoea
- rash/ alopecia
- abdominal cramps
infrequent adverse effects if hydroxychloroquine:
- absent deep tendon reflexes
- muscle weakness
- neuromyopathy
What are the indications to use sulfasalazine?
- rheumatoid arthritis
- ulcerative colitis & chrons disease
Biological DMARDs (bDMARDs) are also known as…….
cytokine modulators
bDMARDs can act in different ways including….
- directly against pro-inflammatoy cytokines (TNF, IL-1 and IL6)
- act through B or T lymphocytes to decrease cytokine production